高水平文章
Sun Zeren#, Xu Dengqiu#, Zhao Lei, Li Xihua, Li Sijia, Huang Xiaofei, Li Chunjie, Sun Lixin, Liu Bing, Jiang Zhenzhou*, Zhang Luyong*. A new therapeutic effect of fenofibrate in Duchenne muscular dystrophy: The promotion of myostatin degradation. British Journal of Pharmacology. 2022, 179(6): 1237-1250.
Xu Dengqiu, Wang Lu, Li Sijia, Jiang Jingwei, Zhao Lei, Huang Xiaofei, Sun Zeren, Li Chunjie, Sun Lixin, Li Xihua*, Jiang Zhenzhou*, Zhang Luyong*. TAK1 inhibition improves myoblast differentiation and alleviates fibrosis in a mouse model of Duchenne muscular dystrophy. Journal of Cachexia, Sarcopenia and Muscle. 2021, 12(1): 192-208.
Tailin He#, Jialin Shang#, Cheng-Long Gao, Xin Guan, Yingyi Chen, Li-Wen Zhu, Luyong Zhang, Cun-Jin Zhang*, Jian Zhang*, Tao Pang*. A novel SIRT6 activator ameliorates neuroinflammation and ischemic brain injury via EZH2/Foxc1 axis. Acta Pharm Sin B. 2021, 11(3): 708-726. (IF: 11.413)
Xu Dengqiu, Zhao Lei, Jiang Jingwei, Li Sijia, Sun Zeren, Huang Xiaofei, Li Chunjie, Wang Tao, Sun Lixin, Li Xihua*, Jiang Zhenzhou*, Zhang Luyong*. A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1.Journal of Cachexia, Sarcopenia and Muscle. 2020, 11(5): 1306-1320.
Yuan Ziqiao, Liang Peishi, Muhammad Hasnat, Yuan Zihang, Zhang Haoran, Sun Lixin, Jiang Zhenzhou*, Zhang Luyong*. A new perspective of Triptolide-associated hepatotoxicity: The relevance of NF-κB and NF-κB-mediated cellular FLICE-inhibitory protein. Acta Pharmaceutica Sinica B. 2020, 10(5): 861-877.
Cheng-Long Gao#, Gui-Ge Hou#, Jin Liu#, Tong Ru, Ya-Zhou Xu, Shun-Yi Zhao, Hui Ye, Lu-Yong Zhang, Kai-Xian Chen, Yue-Wei Guo*, Tao Pang*, Xu-Wen Li*. Synthesis and target identification of benzoxepane derivatives as potential anti-neuroinflammatory agents for ischemic stroke. Angew Chem Int Ed Engl. 2020, 59(6): 2429-2439.
Haojie Wang#, Xiao Xu#, Xin Guan, Shiyang Shen, Xuechao Huang, Guoyin Kai, Shunyi Zhao, Wenchen Ruan, Luyong Zhang, Tao Pang*, Ran Mo*. Liposomal 9-aminoacridine for treatment of ischemic stroke: from drug discovery to drug delivery. Nano Lett. 2020, 20(3): 1542-1551.
Jun Liu, Ying Yuan, Wenna Chen, Juan Putra, Arief A. Suriawinata, Austin D. Schen, Halli Miller, Indira Guleria, Richard J. Barth, Yina H. Huang, Li Wang. Non-redundant regulation of murine T cell responses by VISTA and PD-1 immune-checkpoints. PNAS 2015, 112 (21): 6682-66873.
Li Wang, Isabella Le Mercier, Juan Putra, Wenna Chen, Jun Liu, et al. Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity. PNAS 2014, 111(41): 14846-51.
Cheng-Long Gao#, Ya-Zhou Xu#, Zhuang-Zhuang Liang#, Yun-Jie Wang, Qing-Hong Shang, Sheng-Bin Zhang, Cun-Fang Wang, Ming-Min Ni, Da-Lei Wu, Zhang-Jian Huang*, Tao Pang*. A novel PGAM5 inhibitor LFHP-1c protects blood-brain barrier integrity in ischemic stroke. Acta Pharm Sin B. 2021, 11(7): 1867-1884.